IL136977A0 - Novel optically active aminopentane derivatives - Google Patents

Novel optically active aminopentane derivatives

Info

Publication number
IL136977A0
IL136977A0 IL13697799A IL13697799A IL136977A0 IL 136977 A0 IL136977 A0 IL 136977A0 IL 13697799 A IL13697799 A IL 13697799A IL 13697799 A IL13697799 A IL 13697799A IL 136977 A0 IL136977 A0 IL 136977A0
Authority
IL
Israel
Prior art keywords
optically active
novel optically
disease
composition
derivatives
Prior art date
Application number
IL13697799A
Other languages
English (en)
Original Assignee
Fujimoto Brothers Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujimoto Brothers Co Ltd filed Critical Fujimoto Brothers Co Ltd
Publication of IL136977A0 publication Critical patent/IL136977A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
IL13697799A 1998-10-29 1999-10-15 Novel optically active aminopentane derivatives IL136977A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34775698A JP4499208B2 (ja) 1998-10-29 1998-10-29 新規な光学活性アミノペンタン誘導体
PCT/JP1999/005729 WO2000026204A1 (fr) 1998-10-29 1999-10-15 Nouveau derive d'aminopentane optiquement actif

Publications (1)

Publication Number Publication Date
IL136977A0 true IL136977A0 (en) 2001-06-14

Family

ID=18392375

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13697799A IL136977A0 (en) 1998-10-29 1999-10-15 Novel optically active aminopentane derivatives

Country Status (17)

Country Link
US (1) US6391914B1 (zh)
EP (1) EP1052259B1 (zh)
JP (1) JP4499208B2 (zh)
KR (1) KR100603112B1 (zh)
CN (1) CN1131858C (zh)
AT (1) ATE360009T1 (zh)
AU (1) AU762995B2 (zh)
CA (1) CA2317036C (zh)
DE (1) DE69935849T2 (zh)
DK (1) DK1052259T3 (zh)
ES (1) ES2285861T3 (zh)
HK (1) HK1032585A1 (zh)
HU (1) HU228299B1 (zh)
IL (1) IL136977A0 (zh)
PT (1) PT1052259E (zh)
SI (1) SI20209A (zh)
WO (1) WO2000026204A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4691230B2 (ja) * 2000-04-11 2011-06-01 株式会社フジモト・コーポレーション 光学活性１−（ベンゾフラン−２−イル）−２−プロピルアミノペンタンの製造方法
JP4888751B2 (ja) * 2001-09-14 2012-02-29 株式会社フジモト・コーポレーション トリフルオロプロピルアミノペンタン誘導体及びその製造方法
JP4953040B2 (ja) * 2001-09-19 2012-06-13 株式会社フジモト・コーポレーション アポトーシス抑制剤
JP5030194B2 (ja) * 2004-11-25 2012-09-19 国立大学法人九州大学 薬物依存症治療剤
US20100137429A1 (en) * 2007-06-21 2010-06-03 Fujimoto Co., Ltd. Composition for transdermal or transmucosal administration
AU2014371437B2 (en) * 2013-12-25 2020-01-30 Fujimoto Co., Ltd. Prophylactic and therapeutic agent for attention-deficit/hyperactivity disorder
WO2016088111A1 (en) * 2014-12-05 2016-06-09 Semmelweis University Arylalkylamine compounds for use in the prevention or treatment of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207280B (en) * 1986-09-25 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing new phenyl-alkyl-amines and pharmaceutical compositions containing them
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
JPH0859578A (ja) * 1994-06-17 1996-03-05 Taisho Pharmaceut Co Ltd 置換フェニルアルキルアミン誘導体
KR100572900B1 (ko) 1997-08-07 2006-04-24 후지모토 쿄다이 가부시키가이샤 에틸아민 유도체

Also Published As

Publication number Publication date
JP2000136187A (ja) 2000-05-16
CN1131858C (zh) 2003-12-24
PT1052259E (pt) 2007-07-20
DK1052259T3 (da) 2007-08-06
SI20209A (sl) 2000-10-31
AU762995B2 (en) 2003-07-10
JP4499208B2 (ja) 2010-07-07
CA2317036A1 (en) 2000-05-11
AU6124199A (en) 2000-05-22
EP1052259A4 (en) 2001-10-24
HUP0004667A2 (hu) 2001-04-28
EP1052259A1 (en) 2000-11-15
CN1287554A (zh) 2001-03-14
HU228299B1 (en) 2013-03-28
KR20010033756A (ko) 2001-04-25
HK1032585A1 (en) 2001-07-27
DE69935849T2 (de) 2008-01-10
HUP0004667A3 (en) 2001-10-29
ATE360009T1 (de) 2007-05-15
WO2000026204A1 (fr) 2000-05-11
US6391914B1 (en) 2002-05-21
EP1052259B1 (en) 2007-04-18
DE69935849D1 (de) 2007-05-31
CA2317036C (en) 2009-05-19
KR100603112B1 (ko) 2006-07-20
ES2285861T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
BR9914638A (pt) Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
NO20063275L (no) Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom
BG105112A (en) Agents with antidepressive effect
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
ES2196527T3 (es) Derivados de 11,15-o-dialquilprostaglandina e, su procedimiento de produccion y medicamentos que incluyen estos como principio activo.
JO2372B1 (en) Source drugs of 4-phenylpyridine derivatives
GB0225475D0 (en) Therapeutic agents
PT669920E (pt) 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
BR0206495A (pt) Tratamento de distúrbios de cns empregando antagonistas de oxidase de d-aminoácido e oxidase de d-aspartato
MX2009004898A (es) Derivados de indol y de benzofurano-2-carboxamida.
PE20080364A1 (es) Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa
NO20021875L (no) Fremgangsmåte for stabilisering av benzimidazolforbindelser
DE69835004D1 (de) Neue ethylaminderivate
IL136977A0 (en) Novel optically active aminopentane derivatives
HUP0302478A2 (hu) Modafinil-vegyületek gyógyszerészeti oldatai
BR0011728A (pt) Método de inibir a agregação de proteìna amilóide e imagem de depósitos de amilóide
DK0966277T3 (da) Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
BR0110871A (pt) Derivados de sulfonamida
PT804186E (pt) Compostos alcaloides diterpenicos de indole
BR0110874A (pt) Derivados de sulfonamida
BR0201237A (pt) Processo de obtenção de lignanas dibenzilbutirolactÈnicas, processo de obtenção de derivados sintéticos de lignanas ostentando atividades quimioprofilática e terapêutica antichagásica
HU9701134D0 (en) New coumarin derivatives, processes for the preparation thereof and their use

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees